Evidence map›Paper›PMID 25751620›Full record

ArticlePloS one2015

Efficient differentiation of steroidogenic and germ-like cells from epigenetically-related iPSCs derived from ovarian granulosa cells.

Raymond Anchan, Behzad Gerami-Naini, Jennifer S Lindsey, Joshua W K Ho, Adam Kiezun, Shane Lipskind, Nicholas Ng, Joseph A LiCausi, Chloe S Kim, Paul Brezina and 4 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Pluripotent Cell Models for Gonadal Research.International journal of molecular sciences · 2019
    Review
  9. Review
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 2 countries.

Raymond AnchanDivision of Reproductive Endocrinology and Infertility, Department of Obstetrics, Gynecology and Reproductive Biology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America.
Behzad Gerami-NainiDivision of Genetics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America.
Jennifer S LindseyDivision of Reproductive Endocrinology and Infertility, Department of Obstetrics, Gynecology and Reproductive Biology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America.
Joshua W K HoVictor Chang Cardiac Research Institute and the University of New South Wales, Sydney, New South Wales, Australia.
Adam KiezunComputational Methods Development, Cancer Genome Analysis, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, United States of America.
Shane LipskindDivision of Reproductive Endocrinology and Infertility, Department of Obstetrics, Gynecology and Reproductive Biology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America.
Nicholas NgDivision of Reproductive Endocrinology and Infertility, Department of Obstetrics, Gynecology and Reproductive Biology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America.
Joseph A LiCausiDivision of Reproductive Endocrinology and Infertility, Department of Obstetrics, Gynecology and Reproductive Biology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America.
Chloe S KimDivision of Genetics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America.
Paul BrezinaDepartment of Gynecology and Obstetrics, John's Hopkins University School of Medicine, Baltimore, Maryland, United States of America, and Center for Preimplantation Genetics, LabCorp, Rockville, Maryland, United States of America.
Thomas TuschlLaboratory of RNA Molecular Biology, Howard Hughes Medical Institute, The Rockefeller University, New York, New York, United States of America.
Richard MaasDivision of Genetics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America.
William G KearnsDepartment of Gynecology and Obstetrics, John's Hopkins University School of Medicine, Baltimore, Maryland, United States of America, and Center for Preimplantation Genetics, LabCorp, Rockville, Maryland, United States of America.
Zev WilliamsDivision of Reproductive Endocrinology and Infertility, Department of Obstetrics, and Gynecology and Women's Health, Albert Einstein College of Medicine, Bronx, New York, United States of America.
Brigham and Women's Hospital · USAlbert Einstein College of Medicine · USBroad Institute · USHarvard University · USRockefeller University · USVictor Chang Cardiac Research Institute · AU

Funding

Development of Scholars in Ob-Gyn for the 21th CenturyK12HD001255 · NICHD · BRIGHAM AND WOMEN'S HOSPITAL · PI BARBIERI, ROBERT L · 1999 to 2009
$2.6M
NICHD NIH HHS K12 HD001255
6 · The paper itself

Abstract

To explore restoration of ovarian function using epigenetically-related, induced pluripotent stem cells (iPSCs), we functionally evaluated the epigenetic memory of novel iPSC lines, derived from mouse and human ovarian granulosa cells (GCs) using c-Myc, Klf4, Sox2 and Oct4 retroviral vectors. The stem cell identity of the mouse and human GC-derived iPSCs (mGriPSCs, hGriPSCs) was verified by demonstrating embryonic stem cell (ESC) antigen expression using immunocytochemistry and RT-PCR analysis, as well as formation of embryoid bodies (EBs) and teratomas that are capable of differentiating into cells from all three germ layers. GriPSCs' gene expression profiles associate more closely with those of ESCs than of the originating GCs as demonstrated by genome-wide analysis of mRNA and microRNA. A comparative analysis of EBs generated from three different mouse cell lines (mGriPSCs; fibroblast-derived iPSC, mFiPSCs; G4 embryonic stem cells, G4 mESCs) revealed that differentiated mGriPSC-EBs synthesize 10-fold more estradiol (E2) than either differentiated FiPSC- or mESC-EBs under identical culture conditions. By contrast, mESC-EBs primarily synthesize progesterone (P4) and FiPSC-EBs produce neither E2 nor P4. Differentiated mGriPSC-EBs also express ovarian markers (AMHR, FSHR, Cyp19a1, ER and Inha) as well as markers of early gametogenesis (Mvh, Dazl, Gdf9, Boule and Zp1) more frequently than EBs of the other cell lines. These results provide evidence of preferential homotypic differentiation of mGriPSCs into ovarian cell types. Collectively, our data support the hypothesis that generating iPSCs from the desired tissue type may prove advantageous due to the iPSCs' epigenetic memory.

Indexed as

Epigenesis, GeneticAnimalsCell DifferentiationCells, CulturedEmbryoid BodiesEmbryonic Stem CellsEstradiolFemaleGerm LayersGranulosa CellsHumansInduced Pluripotent Stem CellsKruppel-Like Factor 4Kruppel-Like Transcription FactorsMiceOctamer Transcription Factor-3EstradiolKLF4 protein, humanKlf4 protein, mouseKruppel-Like Factor 4Kruppel-Like Transcription FactorsOctamer Transcription Factor-3ProgesteroneProto-Oncogene Proteins c-mycSOXB1 Transcription Factors

Identifiers

PMID25751620
PMCPMC4353623
OpenAlexW2068469659

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.